Patents by Inventor Kemal Schankereli

Kemal Schankereli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10952844
    Abstract: This invention relates to the design and function of a single-tether compressible valve replacement prosthesis which can be deployed into a beating heart without extracorporeal circulation using a transcatheter delivery system. The design as discussed combats the process of wear on anchoring tethers over time by using a plurality of stent-attached, centering tethers, which are themselves attached to a single anchoring tether, which extends through the ventricle and is anchored to a securing device located on the epicardium.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: March 23, 2021
    Assignee: Tendyne Holdings, Inc.
    Inventors: Robert M. Vidlund, Kemal Schankereli
  • Publication number: 20210023272
    Abstract: The present invention is product and method for treating wounds, or enhancing wound healing, by contacting the wound with biomaterial or tissue that has been treated with a boron and copper composition.
    Type: Application
    Filed: March 23, 2019
    Publication date: January 28, 2021
    Inventor: Kemal Schankereli
  • Patent number: 10639145
    Abstract: This invention relates to the design and function of a compressible valve replacement prosthesis, collared or uncollared, which can be deployed into a beating heart without extracorporeal circulation using a transcatheter delivery system. The design as discussed focuses on the deployment of a device via a minimally invasive fashion and by way of example considers a minimally invasive surgical procedure preferably utilizing the intercostal or subxyphoid space for valve introduction. In order to accomplish this, the valve is formed in such a manner that it can be compressed to fit within a delivery system and secondarily ejected from the delivery system into the annulus of a target valve such as a mitral valve or tricuspid valve.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: May 5, 2020
    Assignee: Tendyne Holdings, Inc.
    Inventors: Robert Vidlund, Kemal Schankereli, Lucian Lozonschi, Georg Lutter
  • Publication number: 20200129667
    Abstract: The present invention is an improved implant made from regenerative tissue or natural tissue, methods of making the implant, and methods of using the implant.
    Type: Application
    Filed: June 30, 2018
    Publication date: April 30, 2020
    Inventors: Richard F. Murphy, Kemal Schankereli, Mark Lauren
  • Patent number: 10617519
    Abstract: This invention relates to the design and function of a compressible valve replacement prosthesis, collared or uncollared, which can be deployed into a beating heart without extracorporeal circulation using a transcatheter delivery system. The design as discussed focuses on the deployment of a device via a minimally invasive fashion and by way of example considers a minimally invasive surgical procedure preferably utilizing the intercostal or subxyphoid space for valve introduction. In order to accomplish this, the valve is formed in such a manner that it can be compressed to fit within a delivery system and secondarily ejected from the delivery system into the annulus of a target valve such as a mitral valve or tricuspid valve.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: April 14, 2020
    Assignee: Tendyne Holdings, Inc.
    Inventors: Robert Vidlund, Kemal Schankereli, Lucian Lozonschi, Georg Lutter
  • Publication number: 20200060814
    Abstract: The present invention is medical device and method for treating venous valve failure or insufficiency. The device is a prosthesis that includes an engineered tissue valve supported by a frame or stent.
    Type: Application
    Filed: December 4, 2017
    Publication date: February 27, 2020
    Inventors: Richard F. Murphy, Kemal Schankereli, Michael L. Davis
  • Publication number: 20200038179
    Abstract: This invention relates to the design and function of a compressible valve replacement prosthesis, collared or uncollared, which can be deployed into a beating heart without extracorporeal circulation using a transcatheter delivery system. The design as discussed focuses on the deployment of a device via a minimally invasive fashion and by way of example considers a minimally invasive surgical procedure preferably utilizing the intercostal or subxyphoid space for valve introduction. In order to accomplish this, the valve is formed in such a manner that it can be compressed to fit within a delivery system and secondarily ejected from the delivery system into the annulus of a target valve such as a mitral valve or tricuspid valve.
    Type: Application
    Filed: October 7, 2019
    Publication date: February 6, 2020
    Applicant: Tendyne Holdings, Inc.
    Inventors: Robert Vidlund, Kemal Schankereli, Lucian Lozonschi, Georg Lutter
  • Publication number: 20200030088
    Abstract: This invention relates to the design and function of a compressible valve replacement prosthesis, collared or uncollared, which can be deployed into a beating heart without extracorporeal circulation using a transcatheter delivery system. The design as discussed focuses on the deployment of a device via a minimally invasive fashion and by way of example considers a minimally invasive surgical procedure preferably utilizing the intercostal or subxyphoid space for valve introduction. In order to accomplish this, the valve is formed in such a manner that it can be compressed to fit within a delivery system and secondarily ejected from the delivery system into the annulus of a target valve such as a mitral valve or tricuspid valve.
    Type: Application
    Filed: October 7, 2019
    Publication date: January 30, 2020
    Applicant: Tendyne Holdings, Inc.
    Inventors: Robert Vidlund, Kemal Schankereli, Lucian Lozonschi, Georg Lutter
  • Publication number: 20190307547
    Abstract: A method for treating at least one of an ophthalmic artery or an ostium between the ophthalmic artery and an internal carotid artery of a subject may include delivering a microcatheter to a location within vasculature of the subject. The method may further include delivering a filter to a location within at least one of the ophthalmic artery or the ostium and transitioning the filter between a first delivery configuration and a second deployed configuration. Further, the method may include deploying a stent to a location within the internal carotid artery.
    Type: Application
    Filed: December 7, 2017
    Publication date: October 10, 2019
    Inventors: Michael CALHOUN, Jeff FRANCO, Kemal SCHANKERELI
  • Patent number: 10398801
    Abstract: Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a proteinaceous substrate and a crosslinking agent, such as a stabilized aldehyde crosslinking agent. Also provided are kits for use in preparing the subject compositions. The subject compositions, kits and systems find use in a variety of different applications.
    Type: Grant
    Filed: April 18, 2018
    Date of Patent: September 3, 2019
    Assignee: BAXTER INTERNATIONAL INC.
    Inventors: Kemal Schankereli, Ronald Dieck
  • Publication number: 20190167424
    Abstract: This invention relates to a delivery apparatus and method for deployment of a mitral valve replacement.
    Type: Application
    Filed: February 7, 2019
    Publication date: June 6, 2019
    Applicant: Tendyne Holdings, Inc.
    Inventors: Robert Vidlund, Kemal Schankereli
  • Patent number: 10219900
    Abstract: This invention relates to a delivery apparatus and method for deployment of a mitral valve replacement.
    Type: Grant
    Filed: April 3, 2017
    Date of Patent: March 5, 2019
    Assignee: Tendyne Holdings, Inc.
    Inventors: Robert Vidlund, Kemal Schankereli
  • Publication number: 20180296721
    Abstract: Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a proteinaceous substrate and a crosslinking agent, such as a stabilized aldehyde crosslinking agent. Also provided are kits for use in preparing the subject compositions. The subject compositions, kits and systems find use in a variety of different applications.
    Type: Application
    Filed: April 18, 2018
    Publication date: October 18, 2018
    Inventors: Kemal Schankereli, Ronald Dieck
  • Patent number: 10098981
    Abstract: Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a proteinaceous substrate and a crosslinking agent, such as a stabilized aldehyde crosslinking agent. Also provided are kits for use in preparing the subject compositions. The subject compositions, kits and systems find use in a variety of different applications.
    Type: Grant
    Filed: July 21, 2015
    Date of Patent: October 16, 2018
    Assignee: Baxter International Inc.
    Inventors: Kemal Schankereli, Ronald Dieck
  • Publication number: 20180147055
    Abstract: This invention relates to the design and function of a compressible valve replacement prosthesis, collared or uncollared, which can be deployed into a beating heart without extracorporeal circulation using a transcatheter delivery system. The design as discussed focuses on the deployment of a device via a minimally invasive fashion and by way of example considers a minimally invasive surgical procedure preferably utilizing the intercostal or subxyphoid space for valve introduction. In order to accomplish this, the valve is formed in such a manner that it can be compressed to fit within a delivery system and secondarily ejected from the delivery system into the annulus of a target valve such as a mitral valve or tricuspid valve.
    Type: Application
    Filed: December 1, 2017
    Publication date: May 31, 2018
    Applicant: Tendyne Holdings, Inc.
    Inventors: Robert VIDLUND, Kemal SCHANKERELI, Lucian LOZONSCHI, Georg LUTTER
  • Publication number: 20180078368
    Abstract: This invention relates to the design and function of a single-tether compressible valve replacement prosthesis which can be deployed into a beating heart without extracorporeal circulation using a transcatheter delivery system. The design as discussed combats the process of wear on anchoring tethers over time by using a plurality of stent-attached, centering tethers, which are themselves attached to a single anchoring tether, which extends through the ventricle and is anchored to a securing device located on the epicardium.
    Type: Application
    Filed: November 21, 2017
    Publication date: March 22, 2018
    Applicant: Tendyne Holdings, Inc.
    Inventors: Robert M. VIDLUND, Kemal SCHANKERELI
  • Patent number: 9833315
    Abstract: This invention relates to the design and function of a compressible valve replacement prosthesis, collared or uncollared, which can be deployed into a beating heart without extracorporeal circulation using a transcatheter delivery system. The design as discussed focuses on the deployment of a device via a minimally invasive fashion and by way of example considers a minimally invasive surgical procedure preferably utilizing the intercostal or subxyphoid space for valve introduction. In order to accomplish this, the valve is formed in such a manner that it can be compressed to fit within a delivery system and secondarily ejected from the delivery system into the annulus of a target valve such as a mitral valve or tricuspid valve.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: December 5, 2017
    Assignee: Tendyne Holdings, Inc.
    Inventors: Robert Vidlund, Kemal Schankereli, Lucian Lozonschi, Georg Lutter
  • Patent number: 9827092
    Abstract: This invention relates to the design and function of a single-tether compressible valve replacement prosthesis which can be deployed into a beating heart without extracorporeal circulation using a transcatheter delivery system. The design as discussed combats the process of wear on anchoring tethers over time by using a plurality of stent-attached, centering tethers, which are themselves attached to a single anchoring tether, which extends through the ventricle and is anchored to a securing device located on the epicardium.
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: November 28, 2017
    Assignee: Tendyne Holdings, Inc.
    Inventors: Robert Vidlund, Kemal Schankereli
  • Publication number: 20170266001
    Abstract: This invention relates to a delivery apparatus and method for deployment of a mitral valve replacement.
    Type: Application
    Filed: April 3, 2017
    Publication date: September 21, 2017
    Applicant: Tendyne Holdings, Inc.
    Inventors: Robert VIDLUND, Kemal SCHANKERELI
  • Patent number: 9675454
    Abstract: This invention relates to a delivery apparatus and method for deployment of a mitral valve replacement.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: June 13, 2017
    Assignee: Tendyne Holdings, Inc.
    Inventors: Robert Vidlund, Kemal Schankereli